Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Avatrombopag vs. Avatrombopag Combined With rhTPO in the Treatment of Patients With Severe Aplastic Anemia

NCT06254287 is registered in ClinicalTrials.gov with Institute of Hematology & Blood Diseases Hospital, China as lead sponsor.

NCT NCT06254287
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06254287 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Avatrombopag vs. Avatrombopag Combined With rhTPO in the Treatment of Patients With Severe Aplastic Anemia
Lead sponsor
Institute of Hematology & Blood Diseases Hospital, China
Phase
Phase 2
Overall status
Unknown status
Start date
February 1, 2024
Completion date
December 31, 2024
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, aplastic